 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
0 Z5 W6 R0 Y2 B# r6 @ 4 l) Q, {; j* ]; g; ^
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
X0 l% P2 P3 e) n, M - |4 s0 q# J2 ]5 M1 S2 s! S$ a
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007/ z8 Y# u: j/ |: s8 v
' h) y3 H2 l. {/ O
; b" @: K# z/ y( M/ g( u- v9 q
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.( |5 U; k7 X- @$ s# u8 v
2 O, p8 x$ `+ i# [8 L; D9 w
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
, t2 Y+ v/ [, B) q: ]. ]/ }
# l$ W8 E6 e# L" S" L( E* sThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.! b) e; e$ D. t" q- T9 T
# j& G' ^( u- }3 a8 O8 P/ R$ |% VIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.1 S+ p6 P: I3 ~: p$ S8 s& H
9 t: Y7 G# ?+ |) I3 I' p2 Y7 [It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
. g/ s: Q$ \+ O5 E) g, e
' E2 l2 E3 O% c7 x2 p9 E7 [4 ~ p"As a scientist, it's one of the highlights of my CAREER," Shan said.2 Y" h/ b" k O* l% F
( M! n* n7 d( A4 {$ J4 r"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
- I3 Q3 p0 B, }0 V; H# T7 n9 T6 Z2 ?1 c: K, ~
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
3 O! q( u" N4 G( p
! t1 m& `, x i6 [1 n) M! rGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.: c. F- k: N8 _0 [
8 L! R& b7 `% H* v
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.- L& m5 ?4 N B9 j9 Q& F6 |. Y
3 ~* Y/ P b7 y: d/ x2 }3 b% ]7 L
8 Y6 w% l! D' Zhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
